UEG Journal's impact and vision for the future
Open Access
- 27 January 2024
- journal article
- editorial
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (3) , 283-285
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysisUnited European Gastroenterology Journal, 2023
- Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohortUnited European Gastroenterology Journal, 2023
- Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohortUnited European Gastroenterology Journal, 2023
- The upward trajectory of the UEG journal: Next Generation Trainee EditorsUnited European Gastroenterology Journal, 2023
- Real‐time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome—A randomized controlled pilot trial (CADLY)United European Gastroenterology Journal, 2022
- Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-UpJournal of Clinical Oncology, 2022
- Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysisUnited European Gastroenterology Journal, 2022
- How to get new guidelines in United European Gastroenterology: Follow the gold!United European Gastroenterology Journal, 2021
- UEG framework for the development of high‐quality clinical guidelinesUnited European Gastroenterology Journal, 2020
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY thresholdExpert Review of Pharmacoeconomics & Outcomes Research, 2008